Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
North America Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The North America injection pen market is expected to grow from US$ 13,156.60 million in 2022 to US$ 20,075.51 million by 2028. It is ... Read More
-
Asia-Pacific Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and End User (Hospitals and Clinics, Home Care, and Others) The Asia-Pacific injection pen market is expected to grow from US$ 11,116.23 million in 2022 to US$ 17,161.96 million by 2028. It is estimated to ... Read More
-
AI in Diabetes Management: Global Market Outlook
... AI in diabetes management and analyzes market trends. Using 2021 as the base year, the report provides estimated market data and revenue projections for the forecast period of 2022-2027. Market values have been estimated based ... Read More
-
Global Women Nutrition Market Size study & Forecast, by Type (Sports Nutrition, Dietary Supplements, Personalized Nutrition and Others), by Product (Vitamins, Proteins, Minerals, Fluids, Probiotics, Omega 3 and Others), by Dosage Form (Solid and Liquid), by Population Type (Adults and Pregnant Women), by Mode of Prescription (Prescription and Over the Counter (OTC)), by Application (Energy & Weight Management, Bone & Joint Health, Immunity, Cardiac Health, Diabetes, Gastrointestinal Health, Ophthalmic Disorders, Neurological Diseases and Others), by Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, Online and Others) and Regional Analysis, 2022-2029
... by Population Type (Adults and Pregnant Women), by Mode of Prescription (Prescription and Over the Counter (OTC)), by Application (Energy & Weight Management, Bone & Joint Health, Immunity, Cardiac Health, Diabetes, Gastrointestinal Health, Ophthalmic Disorders, ... Read More
-
Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis
... according to Renub Research. Almost half a million people in Switzerland have diabetes, which is constantly rising. Diabetes is an essential public health paging, one of four priority non-infectious diseases targeted for action by world ... Read More
-
Pharmaceutical Drug Delivery Market: Trends, Opportunities and Competitive Analysis [2023-2028]
... and home healthcare industries. The global pharmaceutical drug delivery market is expected treach an estimated $2.3 billion by 2028 with a CAGR of 5% from 2023 t2028. The major drivers for this market are growing ... Read More
-
Injection Pen Market By Type (Disposable injection pen, Reusable injection pen), By Therapy (Diabetes, Growth Hormone, Osteoporosis, Fertility, Others), By End Users (Home-care Settings, Hospital and clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031
... injection pen market valued for $37,899.00 million in 2021 and is estimated to reach $80,511.51 million by 2031, exhibiting a CAGR of 7.8% from 2022 to 2031. An injection pen is a medical device used ... Read More
-
Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis
... of 5.92% during the forecast period, 2023-2028, according to Renub Research. Germany has one of the highest diabetes in the European region. The number of type 2 diabetes people will continue to increase over the ... Read More
-
Insulin Pump Market - Global Outlook and Forecast 2023-2028
... Delivery The insulin pump market is constantly evolving with new features with technological advancements like the launch of smarter insulin pumps and more connected devices. Most industry players, such as Medtronic, Tandem Diabetes Care, Insulet ... Read More
-
Japan Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis
... from 2023 to 2028, according to Renub Research. Diabetes is a non-communicable disease caused by high blood glucose levels and is currently one of Japan's most important public health problems. Japan has around 11 million ... Read More
-
Australia Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis
... a CAGR of 7.14% from 2022 to 2028, according to Renub Research. In recent years, Australia diabetes has been on the rise. The diabetes burden in Australia shows no sign of slowing, and its health ... Read More
-
Delayed Onset Type 1 Diabetes
... a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review ... Read More
-
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
... Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others) The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to ... Read More
-
Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 10.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028. Diabetic retinopathy (DR) refers to the damage caused to the blood vessels in the retina by diabetes mellitus. This ailment is of ... Read More
-
Global Electronic Drug Delivery Systems Market Size study & Forecast, by Type (Wearable Infusion Pumps, Autoinjectors, Injection Pens and Inhalers), by Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD and Other Indications) and Regional Analysis, 2022-2029
... Analysis, 2022-2029 Global Electronic Drug Delivery Systems Market is valued approximately USD 9.25 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. ... Read More
-
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... UK, Japan) and provides an Excel-based forecast model for the diabetic neuropathic pain market through 2031. Diabetic neuropathic pain (DNP) is clinically defined as pain resulting from peripheral, autonomic, focal, or proximal nerve damage in ... Read More
-
2023 Global: Blood Glucose Monitoring System Market - Innovative Markets Forecast (2029) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
Global Microkeratome Market Size, Trends & Growth Opportunity, By Product (Disposable, and Reusable), By Technology (Fully Invasive, and Minimally Invasive), By Treatment (Epiretinal Membrane, Diabetic Retinopathy, Retinal Detachment, and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
... & Forecast, 2022 – 2027. Global Microkeratome Market Global Microkeratome Market was valued at USD 878.90 million in 2022 and is slated to reach at USD 1340.26 million by 2027 at a CAGR of 9.2% ... Read More
-
Global Microkeratome Market Size, Trends & Growth Opportunity, By Product (Disposable, and Reusable), By Technology (Fully Invasive, and Minimally Invasive), By Treatment (Epiretinal Membrane, Diabetic Retinopathy, Retinal Detachment, and Others), By Region and Forecast till 2027
... 2027 Global Microkeratome Market Global Microkeratome Market was valued at USD 878.90 million in 2022 and is slated to reach at USD 1340.26 million by 2027 at a CAGR of 9.2% from 2022-2027. Microkeratome is ... Read More
-
Global Biosimilars Insulin Market Growth 2023-2029
... and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference insulin product and is already been approved by FDA or licensed. The producers of biosimilars use the similar manufacturing ... Read More
-
Global Stem Cell Therapy for Diabetes and Related Conditions Market Growth (Status and Outlook) 2023-2029
... two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). LPI (LP Information)' newest research report, the “Stem Cell Therapy for Diabetes and Related Conditions Industry ... Read More
-
Global Lifestyle Diseases Apps Market Size study & Forecast, by Platform Type (iOS, Android, Others), by Device (Smartphones, Tablets, Wearables), by Indication (Obesity, Cardiovascular Health, Mental Health, Diabetes, Others) and Regional Analysis, 2022-2029
... Diseases Apps Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.7% over the forecast period 2022-2029. Lifestyle diseases apps are ... Read More
-
Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027
... global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period. Market growth is driven by factors such as ... Read More
-
Enteral Feeding Devices Market by Type (Feeding Tube (Gastrostomy, Jejunostomy), Feeding Pump, Giving Set), Age Group (Adult, Pediatric), Application (Diabetes, Neurological Disorder, Cancer), End User (Hospital, ACS, Home Care) - Global Forecast to 2027
... global enteral feeding devices market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, growing at a CAGR of 6.9% during the forecast period. Rapid growth in geriatric population ... Read More
-
Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 68.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.48% during 2023-2028. Human insulin (HI) is a short-acting form of insulin used to treat hyperglycemia caused by type 1 and type 2 diabetes. It ... Read More
Research Assistance
